A detailed history of Gts Securities LLC transactions in Novavax Inc stock. As of the latest transaction made, Gts Securities LLC holds 266,400 shares of NVAX stock, worth $2.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
266,400
Previous 506,800 47.43%
Holding current value
$2.27 Million
Previous $6.42 Million 47.57%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$10.71 - $17.11 $498,025 - $795,632
46,501 New
46,501 $587,000
Q3 2023

Nov 15, 2023

BUY
$6.81 - $9.74 $80,787 - $115,545
11,863 New
11,863 $85,000

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $666M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.